<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">
<channel xmlns:cfi="http://www.microsoft.com/schemas/rss/core/2005/internal" cfi:lastdownloaderror="None">
<title cf:type="text"><![CDATA[Editorial Board of Journal of Pharmaceutical Research -->Circulation Pharmacy]]></title>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[关于生物医药园区建设的几点建议]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201409017&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[]]></description>
<pubDate>2017/1/11 15:15:50</pubDate>
<category><![CDATA[Circulation Pharmacy]]></category>
<author><![CDATA[徐东<sup>1,2,3</sup>,孙晓晓<sup>2,3</sup>,邹方琮<sup>2,3</sup>]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>徐东<sup>1,2,3</sup>,孙晓晓<sup>2,3</sup>,邹方琮<sup>2,3</sup></atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201409017&flag=1]]></guid><cfi:id>7</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[医院制剂监督抽验中存在的问题及建议]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201408018&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[]]></description>
<pubDate>2017/2/23 9:10:30</pubDate>
<category><![CDATA[Circulation Pharmacy]]></category>
<author><![CDATA[李佐法<sup>1</sup>,王波<sup>2</sup>,冉晓静<sup>2</sup>]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>李佐法<sup>1</sup>,王波<sup>2</sup>,冉晓静<sup>2</sup></atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201408018&flag=1]]></guid><cfi:id>6</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[患者选择药店购药行为意向理论模型的构建——基于计划行为理论框架下的研究]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201407017&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[]]></description>
<pubDate>2017/2/23 10:23:47</pubDate>
<category><![CDATA[Circulation Pharmacy]]></category>
<author><![CDATA[刘欣,常峰]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>刘欣,常峰</atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201407017&flag=1]]></guid><cfi:id>5</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis on the situation of drug GMP certification inspection for Shandong Province in 2015]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201607018&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<i>Good Manufacturing Practice</i> (<i>Revised</i> 2010) had been formally promulgated and implemented for five years. However, there were still various weakness for certain pharmaceutical enterprises in the production quality management from the analysis on the situation of the certification inspection in 2015.This paper aimed to discover the outstanding problems existing in pharmaceutical production enterprises for the industry through the comparative analysis of the annual inspection defect items in 2015 and 2014. At the same time, this paper also provided improvement suggestion for pharmaceutical enterprises.]]></description>
<pubDate>2016/7/12 0:00:00</pubDate>
<category><![CDATA[Circulation Pharmacy]]></category>
<author><![CDATA[HAN Ying, BAI Jianxue, XU Dan, CAO Hongyan, HU Jingfeng and CHAI Fayong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>HAN Ying, BAI Jianxue, XU Dan, CAO Hongyan, HU Jingfeng and CHAI Fayong</atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201607018&flag=1]]></guid><cfi:id>4</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis on the online filing situation of domestic non-special use cosmetics in Shandong Province]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201606019&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>Objective</b>  To analyze the online filing situation of domestic non-special use cosmetics in Shandong Province,so as to provide technical references for the supervision of cosmetics.<b>Methods</b>  The numbers of cosmetics applied and approved in the online filing system from July 2014 to December 2015 were collected,the main problems found during evaluation were summarized,and recommendations were made accordingly.<b>Results and Conclusion</b>  The policies and regulations of online filing should be further publicized and implemented,and postmortem supervision should be strengthened to standardize the online filing work and promote self-discipline and development of the enterprises.]]></description>
<pubDate>2016/6/21 15:47:30</pubDate>
<category><![CDATA[Circulation Pharmacy]]></category>
<author><![CDATA[TANG Zian and HU Xiaotong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>TANG Zian and HU Xiaotong</atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201606019&flag=1]]></guid><cfi:id>3</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Discussion on the development of medical electronic commerce in the era of ‘Internet +’]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201601018&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[‘Internet +’ action plan of China is an important part of the innovated and driven development under the “new normal”.It is one of the strategic measures to enhance the real economy and the productive forces.The current medical electronic commerce in our country is still in its infancy, backward and slow.At the same time,it also exists some problems of the policy barriers,the non-perfect logistics distribution system,the potential risk and health care regulation.So it is important to promote the healthy development of medical electronic commerce by establishing the relevant laws and regulations,the medical third-party logistics services,standardized means of payment and the establishment of the credit market.]]></description>
<pubDate>2016/3/22 10:16:56</pubDate>
<category><![CDATA[Circulation Pharmacy]]></category>
<author><![CDATA[YANG Xinyi<sup>1</sup> and LIU Yongjun<sup>2</sup>]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>YANG Xinyi<sup>1</sup> and LIU Yongjun<sup>2</sup></atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201601018&flag=1]]></guid><cfi:id>2</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The enlightenment of quality control and quality assurance of drug purchasing in Hong Kong]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201706016&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>Objective</b>  To provide experiences for drug purchasing in mainland by studying the quality control and quality assurance of drug purchasing in Hong Kong.<b>Methods</b>  The general situation of drug purchasing in Hong Kong was summarized,and drug purchasing in Hong Kong was analyzed from quality control and quality assurance.<b>Results and Conclusion</b>  The Hong Kong drug expenditure accounted for 9%~10% of appropriate funds,that depends on purchasing management for cost in Hong Kong.In drug purchasing,quality control and quality assurance ensure the curative effect of all kinds of drugs.Recommendations: to improve the specialized skill of purchasing department,build a platform for information,strengthen the pre-test and on-site inspection,the use of blacklist system,the use of product liability insurance.]]></description>
<pubDate>2017/6/19 13:58:15</pubDate>
<category><![CDATA[Circulation Pharmacy]]></category>
<author><![CDATA[ZHU Lisha, HOU Lili, LI Pengfei and SHAO Rong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>ZHU Lisha, HOU Lili, LI Pengfei and SHAO Rong</atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=201706016&flag=1]]></guid><cfi:id>1</cfi:id><cfi:read>true</cfi:read></item>
</channel>
</rss>